From near-zero to zero fluoroscopy catheter ablation procedures.
Action Potentials
Adult
Aged
Arrhythmias, Cardiac
/ diagnosis
Atrial Flutter
/ diagnosis
Catheter Ablation
/ adverse effects
Clinical Competence
Electrophysiologic Techniques, Cardiac
/ adverse effects
Female
Fluoroscopy
Heart Rate
Humans
Learning Curve
Male
Middle Aged
Prospective Studies
Radiation Dosage
Radiation Exposure
/ adverse effects
Radiography, Interventional
/ adverse effects
Risk Factors
Surgery, Computer-Assisted
/ instrumentation
Tachycardia, Atrioventricular Nodal Reentry
/ diagnosis
Tachycardia, Supraventricular
/ diagnosis
Tachycardia, Ventricular
/ diagnosis
Time Factors
Treatment Outcome
Ventricular Premature Complexes
/ diagnosis
catheter ablation
electroanatomic mapping without fluoroscopy
zero fluoroscopy
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
18
05
2019
revised:
03
08
2019
accepted:
11
08
2019
pubmed:
20
8
2019
medline:
21
10
2020
entrez:
20
8
2019
Statut:
ppublish
Résumé
The use of electroanatomical mapping (EAM) systems can reduce radiation exposure (RX) and it can also completely eliminate the use of RX. Radiation exposure related to conventional radiofrequency ablation procedures can have a stochastic and deterministic effect on health. The main aim of this study was to evaluate the safety and feasibility of an entirely nonfluoroscopic approach to catheter ablation (CA) using EAM CARTO3. In 2011 we started an RX-minimization programme in all procedures using the CARTO system with the deliberate intention to not resort to the aid of RX unless strictly necessary. We divided procedures into two groups (group 1: from 2011 to 2013; group 2: from 2014 to 2017). The only exclusion criteria were the need for transseptal puncture, and nonidiopathic ventricular tachycardia (VT). From a total of 525 procedures, we performed CA entirely without RX in 78.5% of cases. From 2011 to 2013, we performed CA without RX in 38.5% of cases; from 2014 to 2017, we performed 96.2% of cases with zero RX. The use of RX was significantly reduced in group 2 (group 2: 1.4 ± 19.6 seconds vs group 1: 556.92 ± 520.76 seconds; P < .001). These differences were irrespective of arrhythmia treatment. There were no differences between the two groups in acute success, complications, or duration of procedures. CA of supraventricular tachycardia and VT entirely without RX, guided by the CARTO system, is safe, feasible, and effective. After an adequate learning curve, CA can be performed entirely without RX.
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2397-2404Informations de copyright
© 2019 Wiley Periodicals, Inc.